The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 623 | 63,750 | SH | DFND | 63,750 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 276 | 6,000 | SH | DFND | 6,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 2,105 | 36,000 | SH | DFND | 36,000 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 768 | 364,132 | SH | DFND | 364,132 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 805 | 15,750 | SH | DFND | 15,750 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 2,001 | 458,887 | SH | DFND | 458,887 | 0 | 0 | ||
| LIVONGO HEALTH INC | COM | 539183103 | 2,568 | 90,000 | SH | DFND | 90,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 703 | 15,000 | SH | DFND | 15,000 | 0 | 0 | ||
| ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 22,306 | 2,962,267 | SH | DFND | 2,962,267 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 2,469 | 828,413 | SH | DFND | 828,413 | 0 | 0 | ||
| PRECISION BIOSCIENCES INC | COM | 74019P108 | 5,672 | 940,560 | SH | DFND | 940,560 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 1,749 | 39,362 | SH | DFND | 39,362 | 0 | 0 | ||
| UNUM THERAPEUTICS INC | COM | 903214104 | 389 | 940,805 | SH | DFND | 940,805 | 0 | 0 | ||